Pamela D. Garzone

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

Medicine, Oncology, Pharmacology +15

Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9

Javier Chaparro‐Riggers, Liang Hong, Rachel M. DeVay et al. · Journal of Biological Chemistry · 2012 · 165 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Clinical evaluation of recombinant factor IX.

G. White, Amy D. Shapiro, Margaret V. Ragni et al. · PubMed · 1998 · 107 citations

Medicine, Hematology, Hemostasis +7

Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program

Marcelo E. Bigal, Rafael Escandón, Michele Bronson et al. · Cephalalgia · 2013 · 94 citations

Medicine, Pharmacology, Pharmacotherapy +12

Immunomodulatory activity of humanized anti–IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes

Kevan C. Herold, Samantha Bucktrout, Xiao Wang et al. · JCI Insight · 2019 · 40 citations · Full text

Life Sciences, Endocrinology, Immunology +17